Evidence map›Paper›PMID 42739661›Full record

ArticleJournal of clinical medicine2026

Etelcalcetide Versus Cinacalcet for Secondary Hyperparathyroidism in Hemodialysis Patients: A Multicentre Comparison with 24 Months of Follow-Up.

Hakkı Öztürk, Çiğdem Ikhlef, Berrak Itır Aylı, Veysel Baran Tomar, Bartu Ediz, Ebru Gök Oğuz, Elif Arı Bakır, Galip Güz, Mehmet Deniz Aylı

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hakkı ÖztürkAfyonkarahisar Provincial Health Services Directorate, Afyonkarahisar 03200, Türkiye.
Çiğdem IkhlefDivision of Nephrology, Department of Internal Medicine, Ankara Etlik City Hospital, Ankara 06170, Türkiye.
Berrak Itır AylıFaculty of Life Sciences, University of Westminster, London W1B 2HW, UK.ORCID 0000-0002-0834-900X
Veysel Baran TomarDepartment of Nephrology, Faculty of Medicine, Gazi University, Ankara 06570, Türkiye.ORCID 0000-0003-2123-5207
Bartu EdizDepartment of Nephrology, Kartal Dr Lütfü Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0009-0000-9588-4803
Ebru Gök OğuzDivision of Nephrology, Department of Internal Medicine, Ankara Etlik City Hospital, Ankara 06170, Türkiye.
Elif Arı BakırDepartment of Nephrology, Kartal Dr Lütfü Kırdar City Hospital, Istanbul 34865, Türkiye.
Galip GüzDepartment of Nephrology, Faculty of Medicine, Gazi University, Ankara 06570, Türkiye.
Mehmet Deniz AylıDivision of Nephrology, Department of Internal Medicine, Ankara Etlik City Hospital, Ankara 06170, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

calcimimeticcinacalcetCKD-MBDcomparative effectivenessetelcalcetidehemodialysispropensity score matchingreal-world evidencesecondary hyperparathyroidism

Identifiers

PMID42739661
PMCPMC13566838

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.